High Park Farms will begin cultivating cannabis plants in its greenhouse next week
Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park has secured the exclusive rights to produce and distribute a broad-based portfolio of adult-use cannabis brands and products in Canada
Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists.
This strategic alliance represents another major milestone in the recognition of medical cannabis and cannabinoids as conventional medicine.
Tilray is welcoming seasoned financial executive Mark Castaneda, who has a strong record of success in the CFO role in a number of industries, as CFO.
Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has ever been legally exported to and made available for medical purposes in the country of South Africa and on the continent of Africa.